Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2016
Perceived Health Risks of Snus and Medicinal Nicotine Products.
Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 23 citations in OpenAlex.
- Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.Tobacco control · 2019Trial
- Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks.Tobacco control · 2018Trial
- Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes.Addiction (Abingdon, England) · 2016Trial
- Effects of cigarette greenwashing advertising on behavioral economic demand, puff topography, and health risk perception.Journal of the experimental analysis of behavior · 2026Article
- Effects of unventilated versus ventilated filtered cigarettes on smoking behaviour and biomarkers of smoke exposure in a randomised clinical trial.Tobacco control · 2026Article
- Evaluating the human abuse potential of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke.Experimental and clinical psychopharmacology · 2025Article
- Cravings, Control, and Cessation: A Scoping Review of Perceptions of Nicotine Addiction.Current addiction reports · 2025Review
- Effect of nicotine expectancy and nicotine dose reduction on cigarette demand, withdrawal alleviation, and puff topography.Drug and alcohol dependence · 2024Article
- Smokeless Tobacco in Uganda: Perceptions among Tobacco Control Stakeholders.International journal of environmental research and public health · 2022Article
- Appeal, subjective effects, and relative reinforcing effects of JUUL that vary in flavor and nicotine content.Experimental and clinical psychopharmacology · 2021Article
- Biopsychosocial mechanisms associated with tobacco use in smokers with and without serious mental illness.Preventive medicine · 2020Article
- Worry about lung cancer is related to numeracy and risk perception of diseases associated with smoking.American journal of health education · 2020Article
- Effects of Cigarette Nicotine Content and Menthol Preference on Perceived Health Risks, Subjective Ratings, and Carbon Monoxide Exposure Among Adolescent Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019Article
- Assessing likelihood of product use for snus with modified-risk information among adult current cigarette smokers, former tobacco users, and never tobacco users.Addictive behaviors reports · 2019Article
- Estimating Uptake for Reduced-nicotine Cigarettes Using Behavioral Economics.Tobacco regulatory science · 2019Article
- Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes.Drug and alcohol dependence · 2019Article
- Article
- Low Nicotine Content Descriptors Reduce Perceived Health Risks and Positive Cigarette Ratings in Participants Using Very Low Nicotine Content Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017Article
- Behavioral economic substitution between conventional cigarettes and e-cigarettes differs as a function of the frequency of e-cigarette use.Drug and alcohol dependence · 2017Article
- Persistence and amplitude of cigarette demand in relation to quit intentions and attempts.Psychopharmacology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
introductionPerceived health risk (PHR) of a tobacco product may influence both uptake and continued use. In this study, we examined PHRs of snus and medicinal nicotine using the PHR scale and the relationship of PHR responses to use of these products in smokers seeking an alternative to smoking.
methodsSmokers were randomly assigned to snus or to medicinal nicotine for a period of 12 weeks and asked to only use the assigned product. The PHR scale involves rating the extent of perceived risk of a product for different diseases and was given at baseline and weeks 4 and 12 during treatment. Relationships between PHR scale scores and study attrition, compliance with only using the product, and continued use of the product after treatment were determined.
resultsResponse to the PHR scale showed no significant differences between the snus and medicinal nicotine for perceived risks for lung cancer, emphysema, and bronchitis. However, significant differences were observed for other cancers, heart disease, stroke and risk for addiction, particularly after product use, with higher scores among those assigned to snus. Scores on the PHR scale were not related to any of the trial outcome variables.
conclusionsAmong smokers seeking an alternative to smoking in a clinic setting, PHR of a product changes after product use but may not be related to product use patterns. IMPLICATIONS: PHRs of snus or medicinal nicotine in smokers assigned to these products become more accurate after product use. PHR does not appear to be associated with patterns of product use; rather satisfaction with a product is a better indicator as to whether a smoker is compliant with only using the product or continues to use the product.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.